Where to Buy Letu/Letrozol: Vendor Comparison & Research Info

Letu (Letrozole) is a non-steroidal aromatase inhibitor widely studied in oncology, endocrinology, and steroid-metabolism research. It selectively inhibits the aromatase enzyme, making it a useful research compound for investigating estrogen biosynthesis, hormone-dependent cellular signaling, and endocrine feedback mechanisms.

Overview

Letrozole belongs to the triazole class of aromatase inhibitors and acts by reducing the conversion of androgenic hormones into estrogens. This mechanism makes it particularly relevant to research involving estrogen-dependent tumors, ovarian function, steroid metabolism, and hormonal regulation.

In laboratory and preclinical models, letrozole is investigated to better understand how changes in estrogen availability influence cellular proliferation, gene expression, reproductive signaling, and tissue-specific physiology.

Molecular Characteristics and Chemical Profile

• Active Ingredient: Letrozole

• Chemical Class: Non-steroidal aromatase inhibitor

• Chemical Formula: C₁₇H₁₁N₅

• Molecular Weight: 285.30 g/mol

• CAS Number: 112809-51-5

• Chemical Name: 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile

• Form: Research compound

Research Applications

Letrozole is investigated across several scientific fields, including:

• Aromatase enzyme inhibition

• Estrogen biosynthesis

• Breast cancer research

• Endocrine signaling

• Ovarian and reproductive biology

• Steroid metabolism

• Hormone-dependent cellular proliferation

• Bone and mineral metabolism

• Pharmacokinetic research

Mechanism of Action

Aromatase, encoded by the CYP19A1 gene, catalyzes the conversion of androgens into estrogenic hormones. Letrozole binds to the aromatase enzyme and inhibits this conversion, resulting in reduced estrogen biosynthesis.

Key Mechanistic Features

Aromatase Suppression:
Letrozole inhibits CYP19A1 activity, providing a controlled model for studying estrogen production.

Estrogen Signaling Research:
Reduced estrogen availability allows researchers to examine changes in estrogen receptor activation and downstream gene transcription.

Steroid Conversion:
The compound provides a useful tool for studying the biochemical conversion of testosterone- and androstenedione-derived substrates into estrogens.

Endocrine Feedback:
Researchers can evaluate how alterations in estrogen levels affect hypothalamic and pituitary signaling pathways.

Primary Research Areas

1. Oncology Research

Letrozole is extensively studied in estrogen receptor-positive breast cancer models. Researchers investigate how aromatase inhibition affects estrogen-dependent tumor-cell proliferation and molecular signaling.

2. Reproductive Endocrinology

Preclinical and laboratory studies examine how suppression of estrogen synthesis influences ovarian function, follicular development, gonadotropin signaling, and reproductive hormone interactions.

3. Steroid Metabolism

Letrozole provides an experimental model for examining aromatase-dependent steroid conversion and the broader regulation of androgen and estrogen pathways.

4. Endocrine Signaling

Researchers use aromatase inhibition to investigate feedback relationships between estrogen, testosterone, luteinizing hormone, follicle-stimulating hormone, and other endocrine mediators.

5. Bone Biology

Because estrogen plays an important role in skeletal remodeling, letrozole is also investigated in models examining estrogen depletion, bone turnover, and mineral homeostasis.

Molecular and Cellular Research

Letrozole can be incorporated into controlled experimental models to evaluate:

• CYP19A1 enzyme activity

• Estrogen-dependent gene expression

• Hormone receptor signaling

• Cellular proliferation

• Steroidogenic pathway regulation

• Endocrine feedback responses

• Tissue-specific hormonal effects

These applications make letrozole particularly valuable for mechanistic studies where controlled modulation of estrogen biosynthesis is required.

Pharmacokinetic Research

Research involving letrozole may evaluate absorption, distribution, metabolism, and elimination characteristics. Investigators can examine:

• Plasma exposure

• Metabolic transformation

• Enzyme interactions

• Tissue distribution

• Elimination kinetics

• Pharmacodynamic relationships

Such studies help establish relationships between compound exposure, aromatase inhibition, and downstream hormonal responses.

Analytical Testing

Appropriate analytical verification is important for maintaining consistency in research applications. Common analytical approaches include:

• High-Performance Liquid Chromatography (HPLC)

• Liquid Chromatography–Mass Spectrometry (LC-MS)

• Nuclear Magnetic Resonance (NMR)

• Identity testing

• Purity analysis

• Stability testing

These methods help researchers verify compound identity, chemical purity, and stability.

Storage and Handling

Letrozole should be handled in accordance with applicable laboratory safety procedures and relevant documentation. Proper storage conditions should be maintained to preserve chemical stability and minimize degradation.

Safety & Research Disclaimer

Letrozole is a potent pharmacologically active aromatase inhibitor that can substantially alter estrogen metabolism. Research involving this compound should be performed by qualified personnel using appropriate laboratory controls.

Potential biological effects associated with estrogen suppression include changes in bone metabolism, lipid profiles, reproductive signaling, and other endocrine processes.

Letu / Letrozole is intended for legitimate scientific and research applications only and is not intended for self-administration or unsupervised therapeutic use.